Keckesova et al showed that the mitochondrial serine beta-lactamase-like protein (LACTB) acts as a tumor suppressor that inhibits the proliferation of certain breast cancer cells through inhibition of mitochondrial lipid biosynthesis, by decreasing the PSD enzyme levels (by 60–95%) in mitochondria (20). Here, LACTB is linked to breast cancer.